GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MediciNova Inc (FRA:RMN) » Definitions » Policy Acquisition Expense

MediciNova (FRA:RMN) Policy Acquisition Expense


View and export this data going back to 2013. Start your Free Trial

What is MediciNova Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


MediciNova (FRA:RMN) Business Description

Industry
Traded in Other Exchanges
Address
4275 Executive Square, Suite 300, La Jolla, CA, USA, 92037
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.